DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "African Trypanosomiasis - Pipeline Review, H1 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for African Trypanosomiasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for African Trypanosomiasis and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- African Trypanosomiasis Overview
- Therapeutics Development
- Pipeline Products for African Trypanosomiasis - Overview
- Pipeline Products for African Trypanosomiasis - Comparative Analysis
- African Trypanosomiasis - Therapeutics under Development by Companies
- African Trypanosomiasis - Therapeutics under Investigation by Universities/Institutes
- African Trypanosomiasis Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- African Trypanosomiasis - Products under Development by Companies
- African Trypanosomiasis - Products under Investigation by Universities/Institutes
- African Trypanosomiasis - Companies Involved in Therapeutics Development
- Anacor Pharmaceuticals, Inc.
- Sanofi
- Scynexis, Inc.
For more information visit http://www.researchandmarkets.com/research/m6z826/african
